KLRK1 and neoplasm: TCR γδ cells are capable of tumor-recognition through the γδ TCR and activating receptors shared with natural killer (NK) cells (e.g., NKG2D) (6), and their anti-tumor effects are increasingly being documented in solid tumors as well as in leukemia (7, 8).